Covariate adjustment for two-sample treatment comparisons in randomized clinical trials: a principled yet flexible approach
about
Analysis of time to event outcomes in randomized controlled trials by generalized additive modelsConnections between survey calibration estimators and semiparametric models for incomplete data.Use of auxiliary covariates in estimating a biomarker-adjusted treatment effect model with clinical trial data.Long-term glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as add-on therapy to metformin in patients with type 2 diabetes: 4-year data.Optimal auxiliary-covariate-based two-phase sampling design for semiparametric efficient estimation of a mean or mean difference, with application to clinical trialsDealing with missing outcome data in randomized trials and observational studies.On the covariate-adjusted estimation for an overall treatment difference with data from a randomized comparative clinical trialReduced sample sizes for atrophy outcomes in Alzheimer's disease trials: baseline adjustmentEstimating population treatment effects from a survey subsample.Using audit information to adjust parameter estimates for data errors in clinical trials.Increasing the Efficiency of Prevention Trials by Incorporating Baseline CovariatesInference on treatment effects from a randomized clinical trial in the presence of premature treatment discontinuation: the SYNERGY trial.Statistical interpretation of the RV144 HIV vaccine efficacy trial in Thailand: a case study for statistical issues in efficacy trials.A randomized controlled trial of the efficacy and safety of twice-daily saxagliptin plus metformin combination therapy in patients with type 2 diabetes and inadequate glycemic control on metformin monotherapy.On optimal treatment regimes selection for mean survival time.Semiparametric estimation of treatment effect with time-lagged response in the presence of informative censoring.Variable selection for optimal treatment decision.Treating Parents to Reduce NICU Transmission of Staphylococcus aureus (TREAT PARENTS) trial: protocol of a multisite randomised, double-blind, placebo-controlled trial.Adaptive pre-specification in randomized trials with and without pair-matching.Bias and variance trade-offs when combining propensity score weighting and regression: with an application to HIV status and homeless men.A pilot study comparing in-person and web-based motivational interviewing among adults with a first-time DUI offense.Using a network-based approach and targeted maximum likelihood estimation to evaluate the effect of adding pre-exposure prophylaxis to an ongoing test-and-treat trial.Augmented generalized estimating equations for improving efficiency and validity of estimation in cluster randomized trials by leveraging cluster-level and individual-level covariates.A Sequential Phase 2b Trial Design for Evaluating Vaccine Efficacy and Immune Correlates for Multiple HIV Vaccine RegimensDifferential mental health effects of neighborhood relocation among youth in vulnerable families: results from a randomized trialDapagliflozin's Effects on Glycemia and Cardiovascular Risk Factors in High-Risk Patients With Type 2 Diabetes: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With a 28-Week Extension.Efficient and robust method for comparing the immunogenicity of candidate vaccines in randomized clinical trialsLeveraging prognostic baseline variables to gain precision in randomized trialsAccounting for interactions and complex inter-subject dependency in estimating treatment effect in cluster-randomized trials with missing outcomes.Using regression models to analyze randomized trials: asymptotically valid hypothesis tests despite incorrectly specified models.Variable selection for covariate-adjusted semiparametric inference in randomized clinical trials.Inverse probability weighting for covariate adjustment in randomized studies.A broad symmetry criterion for nonparametric validity of parametrically based tests in randomized trials.Identifying predictive markers for personalized treatment selection.Causation and causal inference for genetic effects.Robustness of ordinary least squares in randomized clinical trials.Empirical likelihood inference in randomized clinical trials.On adjustment for auxiliary covariates in additive hazard models for the analysis of randomized experiments.Boosting the precision of mediation analyses of randomised experiments through covariate adjustment.Comparison of adaptive treatment strategies based on longitudinal outcomes in sequential multiple assignment randomized trials.
P2860
Q27309297-26DE8571-3CDD-4E01-8D87-E5A62F9FB89AQ30653939-8D72845D-78D6-4D43-8F48-A9AD0A6F782AQ30717235-B308DA53-0FFB-4FB4-8D4C-5CA7DF883122Q30903369-C197A3AF-846C-4008-9D38-7107F3ED633FQ33611244-D2048074-78DE-4210-8D9F-5332F8336259Q34133983-F4C15E1E-54A4-4474-8316-68641C27E5F6Q34147369-D266BE00-5156-4F55-B486-E9EA24BBE590Q34163448-4557DA1D-DE8E-4851-9D96-E908C9F5AAC4Q34230241-A6C328F6-C7E4-43F4-9CE5-8653066C2644Q34357603-15E3E839-23B1-44CE-87F4-4F8FA45BCAA9Q34383812-71A39E06-47B0-482A-9056-F22BF2D05CD3Q34706540-49A86DFC-35DE-4ABC-8D14-DE6B83926474Q34743329-405BBD13-8FDC-4C43-9BEC-C921FB0F136FQ35102138-8270C443-616A-4101-805A-B97FA42D8FD3Q35164135-C2E55D2D-81F1-482E-9E57-4E0D12869DBAQ35553170-111BF82B-905F-4040-9C7E-6E07CF468214Q35830773-7D4D635A-C624-4F9B-8F5F-151F74A25186Q36053721-91495A8E-3445-4E19-B97C-707400389D37Q36082493-8CC23C9F-8D3C-44BC-9F67-AE0685155F6AQ36206224-43D76E9D-547D-4F35-9FB7-130D8A810EB8Q36259077-5D3334C3-B991-479E-8F2F-CBAC9D3A92A0Q36260690-9B2A24C6-8803-4179-A4C3-10EFD6631DEBQ36390470-310830C9-D445-4A50-B3EE-7BDE53474AE7Q36413788-97D0C77C-DEEF-42F5-B1E9-634915D5B957Q36776650-F341C623-A4D4-4B39-910D-7044ECF8B3F4Q36798684-A75FFB0A-DA41-462B-A0B5-64CB8148CC35Q37122099-460D893B-05C1-45FD-AA3B-D4E8BC97E299Q37246685-47C22218-2A98-4A24-B198-64B0DEC6C516Q37322419-219D5C2A-0FF4-40AD-923D-0D84F0AF9F85Q37356269-59A66BAE-E0E6-4E54-86D6-EC9BD4EFE4E4Q37374617-55EA38A4-0EB9-4D97-82DF-A459B9065546Q37507573-821C87A2-ABCB-4DCB-9495-AAE4E248C288Q37540544-B8551529-4219-40DA-8A0C-C0D9A66F309CQ37702844-6CB6A82F-AD10-46D5-8EC6-3382BEA04D29Q38032189-F7D5FDDE-B960-4419-9F8C-5BFAD7427EB0Q38676402-9D72920C-AFA4-47E0-8F74-DB63CA67A8DDQ38692539-E614AB0D-752A-435E-95C3-BEB0DBD0BDD2Q38697612-A8B3750D-E299-4C6C-B59D-91FEC7129795Q39029893-44A63B14-8A58-496A-A10B-B1F204FB8434Q39372860-2A57A163-6913-43C5-A045-FAEAC773381D
P2860
Covariate adjustment for two-sample treatment comparisons in randomized clinical trials: a principled yet flexible approach
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Covariate adjustment for two-s ...... incipled yet flexible approach
@en
type
label
Covariate adjustment for two-s ...... incipled yet flexible approach
@en
prefLabel
Covariate adjustment for two-s ...... incipled yet flexible approach
@en
P2093
P2860
P356
P1476
Covariate adjustment for two-s ...... incipled yet flexible approach
@en
P2093
Anastasios A Tsiatis
Marie Davidian
Xiaomin Lu
P2860
P304
P356
10.1002/SIM.3113
P407
P577
2008-10-01T00:00:00Z